CN Patent

CN109125254A — 吗啡调配物、包含所述吗啡调配物的试剂盒和其用途

Assigned to Fresenius Kabi Deutschland GmbH · Expires 2019-01-04 · 7y expired

What this patent protects

本申请案涉及吗啡调配物、包含所述吗啡调配物的试剂盒和其用途。本文总体上提供包含硫酸吗啡或其水合物的医药调配物，例如，具有改进的稳定性的可注射医药调配物；以及其产生和使用方法。本文还提供包含所述调配物，例如可注射吗啡调配物的试剂盒。

USPTO Abstract

本申请案涉及吗啡调配物、包含所述吗啡调配物的试剂盒和其用途。本文总体上提供包含硫酸吗啡或其水合物的医药调配物，例如，具有改进的稳定性的可注射医药调配物；以及其产生和使用方法。本文还提供包含所述调配物，例如可注射吗啡调配物的试剂盒。

Drugs covered by this patent

Patent Metadata

Patent number
CN109125254A
Jurisdiction
CN
Classification
—
Expires
2019-01-04
Drug substance claim
No
Drug product claim
No
Assignee
Fresenius Kabi Deutschland GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.